Fred Telling, Director at CELL THERAPEUTICS INC (CTIC), sold 72,095 shares at $3.76 ($271K) on 2014-03-07, disclosed to the SEC on 2014-03-07.
Open-market sale of $271k CTIC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.73 | 4,500 | $17K | 6.2% |
| 2 | $3.74 | 4,600 | $17K | 6.4% |
| 3 | $3.74 | 7,700 | $29K | 10.6% |
| 4 | $3.75 | 16,815 | $63K | 23.3% |
| 5 | $3.75 | 16,170 | $61K | 22.4% |
| 6 | $3.75 | 390 |
| $1K |
| 0.5% |
| 7 | $3.76 | 5,000 | $19K | 6.9% |
| 8 | $3.76 | 600 | $2K | 0.8% |
| 9 | $3.77 | 23 | $87 | 0.0% |
| 10 | $3.77 | 2,400 | $9K | 3.3% |
| 11 | $3.77 | 4,897 | $18K | 6.8% |
| 12 | $3.78 | 3,200 | $12K | 4.5% |
| 13 | $3.78 | 1,600 | $6K | 2.2% |
| 14 | $3.79 | 300 | $1K | 0.4% |
| 15 | $3.79 | 3,600 | $14K | 5.0% |
| 16 | $3.80 | 300 | $1K | 0.4% |
| Total | $3.75 avg | 72,095 | $271K | 100% |
| Filing → |
| OGEN | SELL | 2024-12-09 | $1K | — | Filing → |
| OGEN | SELL | 2023-12-01 | $12K | — | Filing → |
| OGEN | BUY | 2022-06-21 | $3K | — | Filing → |